Home > National Drug Code (NDC) > Ibandronate Sodium

Ibandronate Sodium - 0591-3770-11 - (ibandronate sodium)

Alphabetical Index


Drug Information of Ibandronate Sodium

Product NDC: 0591-3770
Proprietary Name: Ibandronate Sodium
Non Proprietary Name: ibandronate sodium
Active Ingredient(s): 150    mg/1 & nbsp;   ibandronate sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Ibandronate Sodium

Product NDC: 0591-3770
Labeler Name: Watson Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA079003
Marketing Category: ANDA
Start Marketing Date: 20120320

Package Information of Ibandronate Sodium

Package NDC: 0591-3770-11
Package Description: 1 TABLET in 1 BLISTER PACK (0591-3770-11)

NDC Information of Ibandronate Sodium

NDC Code 0591-3770-11
Proprietary Name Ibandronate Sodium
Package Description 1 TABLET in 1 BLISTER PACK (0591-3770-11)
Product NDC 0591-3770
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ibandronate sodium
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20120320
Marketing Category Name ANDA
Labeler Name Watson Laboratories, Inc.
Substance Name IBANDRONATE SODIUM
Strength Number 150
Strength Unit mg/1
Pharmaceutical Classes Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]

Complete Information of Ibandronate Sodium


General Information